Stock Events

Stock Events

Diasorin S.p.A. 

$67
71
-$3.76-5.31% Monday 17:08

Statistics

Day High
67
Day Low
67
52W High
112.3
52W Low
66.5
Volume
100
Avg. Volume
16
Mkt Cap
0
P/E Ratio
23.35
Dividend Yield
2.23%
Dividend
1.5

Upcoming

19
MAY
Dividend Ex
Increased
 
20
MAY
Dividend Payment
Increased
 
19
MAY 27
Dividend Ex
Estimated
 
20
MAY 27
Dividend Payment
Estimated
 
19
MAY 28
Dividend Ex
Estimated
 
19
MAY 28
Dividend Payment
Estimated
 

Dividends

2.23%Dividend Yield
May 25
$1.35
May 24
$1.25
May 23
$1.19
May 22
$1.12
May 21
$1.22
10Y Growth
7.46%
5Y Growth
4.15%
3Y Growth
7.97%
1Y Growth
10.5%

Earnings

31JulExpected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
0
0.68
1.35
2.03
Expected EPS
N/A
Actual EPS
N/A

Financials

15.86%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.45BRevenue
389.23MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DSRLF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, directly competing with Diasorin in the diagnostics and testing market.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a wide range of diagnostics equipment and tests, including for infectious diseases, competing in the same space as Diasorin.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation owns several companies in the diagnostics sector, including Cepheid and Beckman Coulter, making it a direct competitor.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides a broad array of diagnostics and research products, competing with Diasorin in the life sciences and diagnostics fields.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components, competing in diagnostics.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen N.V. is known for sample and assay technologies for molecular diagnostics, applying competitive pressure in the diagnostics market.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products, competing in the women’s health sector where Diasorin also operates.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company is a global medical technology company that offers diagnostic products and equipment, competing across several of Diasorin’s market segments.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions, competing in the advanced diagnostics field alongside Diasorin.

About

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Show more...
CEO
Mr. Carlo Rosa
Employees
3249
Country
IT
ISIN
IT0003492391

Listings

OTC Link
US
DSRLF
OTC Link
US
DSRNY
F
DE
34D.F
VI
AT
DIAS.VI

0 Comments

Share your thoughts

FAQ

What is Diasorin S.p.A. stock price today?▼
The current price of DSRLF is $67 USD — it has decreased by -5.31% in the past 24 hours. Watch Diasorin S.p.A. stock price performance more closely on the chart.
What is Diasorin S.p.A. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Diasorin S.p.A. stocks are traded under the ticker DSRLF.
What is Diasorin S.p.A. revenue for the last year?▼
Diasorin S.p.A. revenue for the last year amounts to 2.45B USD.
What is Diasorin S.p.A. net income for the last year?▼
DSRLF net income for the last year is 389.23M USD.
Does Diasorin S.p.A. pay dividends?▼
Yes, DSRLF dividends are paid annual. The last dividend per share was 1.35 USD. As of today, Dividend Yield (FWD)% is 2.23%.
How many employees does Diasorin S.p.A. have?▼
As of April 02, 2026, the company has 3,249 employees.
In which sector is Diasorin S.p.A. located?▼
Diasorin S.p.A. operates in the Health Care sector.
When did Diasorin S.p.A. complete a stock split?▼
Diasorin S.p.A. has not had any recent stock splits.
Where is Diasorin S.p.A. headquartered?▼
Diasorin S.p.A. is headquartered in Saluggia, IT.